Trastuzumab Deruxtecan Is Active in Desmoplastic Small Round Cell Tumor We reviewed 168 patients with soft tissue LMS who received systemic therapy between 2009 and 2024 for metastatic LMS and also ...
Between 2013 and 2019, 3,797 patients with unresectable IIIC or stage IV melanoma were entered in the registry and died. The percentage of patients receiving a new systemic therapy within 45 and 90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results